Lack of antidotes called 'serious ethical dilemma' for COVID-19 vaccine challenge trial

Scientists seeking approval to deliberately infect healthy people with COVID-19 in trials must first convince ethics specialists that, among other things, they have potential 'rescue therapies' to halt the disease.